Complications: Urgent C Section VS Elective C Section

This study is currently recruiting participants.

Verified January 2012 by Hadassah Medical Organization

Sponsor:

Information provided by (Responsible Party):

Hadassah Medical Organization

ClinicalTrials.gov Identifier:

NCT01524107

First received: January 30, 2012

Last updated: NA

Last verified: January 2012

History: No changes posted

Purpose

The medical literature does not provide sufficient information or recommendation regarding specific antibiotic coverage for urgent Caesarian sections. The goal of this study is to compare maternal and neonatal morbidity of women who have undergone urgent Caesarian Sections for Prolapsed Cord to those who have undergone Elective Caesarian Sections in order to develop a standard treatment protocol. The Medical Record review will include many parameters including complications, type of antibiotic usage etc.

Condition
Urgent Caesarian Section Secondary to Cord Prolapse

Study Type:	Observational
Study Design:	Observational Model: Case Control Time Perspective: Retrospective
Official Title:	Comparison of Maternal and Fetal Complications After Urgent Caesarian Section for Prolapsed Cord Versus Elective Caesarian Section.

Resource links provided by NLM:

MedlinePlus related topics: Antibiotics Cesarean Section

U.S. FDA Resources

Further study details as provided by Hadassah Medical Organization:

Estimated Enrollment:	240
Study Start Date:	January 2012

Groups/Cohorts
Urgent Caesarian Section
Elective Caesarian Section

Eligibility

Ages Eligible for Study:	20 Years to 40 Years
Genders Eligible for Study:	Female
Accepts Healthy Volunteers:	No
Sampling Method:	Non-Probability Sample

Study Population

Women undergoing Urgent Caesarian Section for Prolapsed Cord and women undergoing Elective Caesarian Section at Hadassah Medical Center-Har HaTzofim.

Criteria

Inclusion Criteria:

women undergoing urgent Caesarian Section for Prolapsed Cord.
women undergoing Elective Caesarian Section.

Exclusion Criteria:

preterm birth
multiple gestation

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT01524107

Contacts

Contact: Drorith Hochner-Celnikier, MD

00 972 2 5844400

hochner@hadassah.org.il

Locations

Israel
Hadassah Medical Organization	Recruiting
Jerusalem, Israel
Contact: Hadas Lemberg, PhD 00 972 2 6777572 lhadas@hadassah.org.il

Sponsors and Collaborators

Hadassah Medical Organization

Investigators

Principal Investigator:

Drorith Hochner-Celnikier, MD

Hadassah Medical Organization

More Information

No publications provided

Responsible Party:	Hadassah Medical Organization
ClinicalTrials.gov Identifier:	NCT01524107 History of Changes
Other Study ID Numbers:	CSURGENT-ELECT-HMO-CTIL
Study First Received:	January 30, 2012
Last Updated:	January 30, 2012
Health Authority:	Israel: Ministry of Health

Keywords provided by Hadassah Medical Organization:

Prophylaxis Antibiotics
Maternal Complications
Neonatal Complications
Cord Prolapse

Elective Caesarian Section
Maternal Morbidity
Neonatal Morbidity

Additional relevant MeSH terms:

Prolapse
Pathological Conditions, Anatomical

ClinicalTrials.gov processed this record on May 16, 2013

To Top